What is Needham's price target for OCX?

Needham's latest stated price target for Oncocyte Corporation (OCX) is $4, from its action on Mar 11, 2022.

What is Needham's rating on OCX?

Needham rates OCX Buy, a bullish rating, as of Mar 11, 2022.

When did Needham last change its view on OCX?

On Mar 11, 2022, Needham cuts its price target to $4 from $5, keeps Buy.

Needham OCX price target and rating history

Oncocyte Corporation (OCX) · Health Care

Needham rates Oncocyte Corporation (OCX) Buy with a $4 price target, as of its latest action on Mar 11, 2022. It has published 3 rating actions on OCX since November 2021, including 0 upgrades and 0 downgrades.

Current rating: Buy
Price target: $4
Median target, all firms: Too few
Actions on OCX: 3

Needham price target on OCX

Needham price target on OCX, each point a stated target, November 2021 to March 2022.

Every Needham rating on OCX

Mar 11, 2022
ReiterateNeedham cuts its price target to $4 from $5, keeps Buy
Dec 16, 2021
ReiterateNeedham cuts its price target to $5 from $7, keeps Buy
Nov 10, 2021
ReiterateNeedham cuts its price target to $7 from $8, keeps Buy

Questions about Needham and OCX

What is Needham's price target for OCX?: Needham's latest stated price target for Oncocyte Corporation (OCX) is $4, from its action on Mar 11, 2022.
What is Needham's rating on OCX?: Needham rates OCX Buy, a bullish rating, as of Mar 11, 2022.
When did Needham last change its view on OCX?: On Mar 11, 2022, Needham cuts its price target to $4 from $5, keeps Buy.

All Needham ratings OCX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.